This topic contains a solution. Click here to go to the answer

Author Question: The difference between an australopithecine like A. africanus and Homo habilis is A) so small ... (Read 62 times)

jace

  • Hero Member
  • *****
  • Posts: 541
The difference between an australopithecine like A. africanus and Homo habilis is
 
  A) so small Homo habilis may be called Australopithecus habilis
  B) nonexistent and the fossil material may be included in Australopithecus africanus
  C) enormous and Homo habilis may be included the genus and species Homo erectus
  D) one of degree and not of kind
  E) varies depending on the individual skeleton

Question 2

Bergmann's rule is based on the fact that loss of body heat increases when the ratio of surface area to body weight goes down.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

joanwhite

  • Sr. Member
  • ****
  • Posts: 308
Answer to Question 1

D

Answer to Question 2

FALSE





 

Did you know?

The average person is easily confused by the terms pharmaceutics and pharmacology, thinking they are one and the same. Whereas pharmaceutics is the science of preparing and dispensing drugs (otherwise known as the science of pharmacy), pharmacology is the study of medications.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Patients who have undergone chemotherapy for the treatment of cancer often complain of a lack of mental focus; memory loss; and a general diminution in abilities such as multitasking, attention span, and general mental agility.

For a complete list of videos, visit our video library